◼ Archived
Health
🔮 fades ✓
GLP-1 weight-loss drugs show promise for sleep apnea
GLP-1 weight-loss drugs could cut sleep-apnea rates, opening a new market and clinical pathway for millions.
Glp-1 Agonists
7 independently detected trends connected to this subject, with the latest coverage first.
What Archynetys tracks about Glp-1 Agonists
This hub groups 7 separate news trends connected to Glp-1 Agonists, spanning June 26, 2026 through September 8, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 54 article observations and 50 source signals, led by Health, Business coverage. Use it to compare how individual events emerged, spread and changed over time.
◼ Archived
Health
🔮 fades ✓
Cravings ‘like heroin withdrawal’: what happens when weight-loss drugs don’t work?
Weight-loss drugs not working as expected lead to withdrawal-like cravings and unexpected side effects.
◼ Archived
Health
Late-life semaglutide treatment slows ageing and extends lifespan in female mice
Recent findings show late-life semaglutide treatment slows ageing and extends lifespan in female mice.
◼ Archived
Business
Eli Lilly is suing six companies over illegal sales of its unapproved weight loss drug
Eli Lilly is suing six companies to stop illegal sales of its unapproved weight loss drug, retatrutide.
◼ Archived
Health
🔮 fades ✓
Type 2 Diabetes: GLP-1 Mounjaro May Lower Heart Attack Risk
A popular diabetes drug may also protect against heart attacks, but the mechanism is still unclear.
◼ Archived
Business
🔮 fades ✓
Eli Lilly to allow more patients to apply for special access to unapproved obesity drug
Eli Lilly is expanding access to its experimental obesity drug, Retatrutide, ahead of approval.
◼ Archived
Health
🔮 fades ✓
Effects of exercise and liraglutide on vascular health and inflammation during weight loss maintenance: a prespecified secondary analysis of the S-LiTE trial
New research reveals the combined effects of exercise and liraglutide on vascular health and inflammation during weight loss maintenance.